Lomtegovimab

Tax included
Lomtegovimab (BI 767551) is a humanized anti-SARS-COV-2 spike glycoprotein monoclonal antibody. Lomtegovimab binds and neutralizes SARS-CoV-2. Lomtegovimab shows antiviral efficacy. Lomtegovimab has the potential for the research of COVID-19.
MedChemExpress 
HY-P99710

Data sheet

Size
Multiple sizes
Reactivity
SARS-CoV
Application
COVID-19-anti-virus
CAS
2550869-33-3